The Current Ratio as of December 2025 (TTM) for Nanjing Vazyme Biotech Co., Ltd. (688105.SS) is 3.73

According to Nanjing Vazyme Biotech Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 3.73. This represents a change of 4.85% compared to the average of 3.56 of the last 4 quarters.

Nanjing Vazyme Biotech Co., Ltd. (688105.SS) Historical Current Ratio (quarterly & annually)

How has 688105.SS Current Ratio performed in the past?

The mean historical Current Ratio of Nanjing Vazyme Biotech Co., Ltd. over the last ten years is 4.42. The current 3.73 Current Ratio has changed 8.34% with respect to the historical average. Over the past ten years (40 quarters), 688105.SS's Current Ratio was at its highest in in the December 2021 quarter at 10.46. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Nanjing Vazyme Biotech Co., Ltd. (688105.SS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Nanjing Vazyme Biotech Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nanjing Vazyme Biotech Co., Ltd. (688105.SS) Average Current Ratio

How has 688105.SS Current Ratio performed in the past?

The current Current Ratio of Nanjing Vazyme Biotech Co., Ltd. (688105.SS) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Nanjing Vazyme Biotech Co., Ltd. (688105.SS) Current Ratio vs. Peers

How is 688105.SS’s Current Ratio compared to its peers?

Nanjing Vazyme Biotech Co., Ltd.’s Current Ratio is greater than Daan Gene Co., Ltd. (3.06), greater than Youcare Pharmaceutical Group Co., Ltd. (1.84), greater than Chengzhi Shareholding Co., Ltd. (1.46), greater than Chengdu Olymvax Biopharmaceuticals Inc. (1.52), greater than Anhui Huaheng Biotechnology Co., Ltd. (1.44), less than Aurisco Pharmaceutical Co.,Ltd. (4.30), greater than Guilin Sanjin Pharmaceutical Co., Ltd. (3.13), less than Chengdu Kanghua Biological Products Co., Ltd. (5.85), greater than Zhejiang Ausun Pharmaceutical Co., Ltd. (2.84), less than Hunan Jiudian Pharmaceutical Co., Ltd. (4.81),

Build a custom stock screener for Nanjing Vazyme Biotech Co., Ltd. (688105.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanjing Vazyme Biotech Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nanjing Vazyme Biotech Co., Ltd. (688105.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nanjing Vazyme Biotech Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.